Dear Head of lab,
The British Heart Foundation and the National Familial
Hypercholesterolaemia (FH) steering group have requested the help
of the ACGS to measure the improvement in ascertainment of FH cases
achieved from the current rounds of investment. Measuring the
benefit of the programme is key to make an argument for sustained
and hopefully extended commissioning for FH testing. The steering
group understand the amount of work involved particularly in
collecting retrospective data, but this is key to establishing a
base line from which to measure improvement. Everyone's efforts
will be greatly appreciated.
The ACGS Quality Subcommittee would like to collect information
from laboratories provided FH testing, thereforewe invite you to
complete the attached survey.
Please complete this electronic copy and email to Sandi Deans at
2nd October 2015.
Thank you for your help.
With best wishes,
Dr Sandi Deans
Chair - ACGS Quality Subcommittee